EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Enox Biopharma, Inc.
(the "Company") for the period ended September 30, 2008, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Prof.
Yossef Av-Gay, principal executive officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge and belief:

     (1)  the Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.


Date: December 11, 2008           By: /s/ Prof. Yossef Av-Gay
                                     -----------------------------------------
                                  Name:  Prof. Yossef Av-Gay
                                  Title: President and Chief Executive Officer
                                         (Principal Executive Officer)